New drug MDI-2517 tested for safety in healthy people
NCT ID NCT07220889
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This early-stage study tested the safety of a new drug called MDI-2517 in 32 healthy adults aged 18 to 55. Participants received either single or multiple doses of the drug or a placebo. Researchers monitored for side effects, lab changes, and heart activity to understand how the drug behaves in the body. The study did not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AFTER ORAL INTAKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
1951 NW 7th Avenue, Suite 180
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.